Showing results (201-210 of 389) with videos related to
Sort By:
Pageof 39
The Journal of Investigative Dermatology|March 14, 2009
Evaluation of the clonal origin of multiple primary melanomas using molecular profilingIrene Orlow, Diana V Tommasi, Bradley Bloom, et al.Cancer Research|December 21, 2006
A systematic assessment of common genetic variation in CYP11A and risk of breast cancerVeronica Wendy Setiawan, Iona Cheng, Daniel O Stram, et al.Annals of Surgical Oncology|September 14, 2011
Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomasRajmohan Murali, Chris Goumas, Anne Kricker, et al.JCO Precision Oncology|March 17, 2023
Pathway Alterations in Stage II/III Primary MelanomaCaroline E Kostrzewa, Li Luo, Arshi Arora, et al.Melanoma Research|August 4, 2026
Association of chemokine and chemokine receptor gene variants with occurrence of multiple primary melanomaIrene Orlow, Li Luo, Isidora Autuori, et al.The Journal of Clinical Endocrinology and Metabolism|December 23, 2011
Shorter androgen receptor CAG repeat lengths associated with cryptorchidism risk among Hispanic white boysCarol Davis-Dao, Chester J Koh, Brian E Hardy, et al.Biorxiv : the Preprint Server for Biology|November 18, 2024
Improving Accuracy of Somatic Mutation Profiling in Large Epidemiologic Studies: Addressing Cases without Matched Normal SamplesArshi Arora, Li Luo, Caroline E Kostrzewa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumorsIrene Orlow, Bernard J Park, Urvi Mujumdar, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
Urinary estrogen metabolites and their ratio among Asian American womenRoni T Falk, Thomas R Fears, Xia Xu, et al.Gynecologic Oncology|May 8, 2026
Estrogen hormone therapy use in ovarian cancer patients under age 60 at diagnosisAlexandra Lukey, Ali Salmanpour, Paramdeep Kaur, et al.Pageof 39